A detailed history of Voya Investment Management LLC transactions in Viking Therapeutics, Inc. stock. As of the latest transaction made, Voya Investment Management LLC holds 674,139 shares of VKTX stock, worth $28.5 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares
674,139
Previous 622,405 8.31%
Holding current value
$28.5 Million
Previous $33 Million 29.36%
% of portfolio
0.05%
Previous 0.04%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$49.84 - $70.47 $2.58 Million - $3.65 Million
51,734 Added 8.31%
674,139 $42.7 Million
Q2 2024

Dec 03, 2024

SELL
$47.39 - $80.2 $2.45 Million - $4.15 Million
-51,734 Reduced 7.67%
622,405 $33 Million
Q2 2024

Aug 14, 2024

SELL
$47.39 - $80.2 $21.1 Million - $35.8 Million
-446,192 Reduced 41.75%
622,405 $33 Million
Q1 2024

Dec 06, 2024

BUY
$17.4 - $94.5 $6.86 Million - $37.3 Million
394,458 Added 58.51%
1,068,597 $87.6 Million
Q1 2024

May 15, 2024

BUY
$17.4 - $94.5 $17.9 Million - $97.3 Million
1,030,157 Added 2679.91%
1,068,597 $87.6 Million
Q4 2023

Feb 14, 2024

SELL
$9.24 - $19.64 $831 - $1,767
-90 Reduced 0.23%
38,440 $715,000
Q3 2023

Nov 14, 2023

BUY
$10.92 - $16.0 $5,077 - $7,440
465 Added 1.22%
38,530 $426,000
Q2 2023

Aug 14, 2023

BUY
$14.84 - $24.79 $564,884 - $943,631
38,065 New
38,065 $617,000
Q2 2022

Aug 15, 2022

SELL
$2.11 - $3.15 $57,790 - $86,275
-27,389 Closed
0 $0
Q4 2021

Feb 14, 2022

SELL
$4.6 - $6.72 $4,434 - $6,478
-964 Reduced 3.4%
27,389 $126,000
Q2 2021

Aug 16, 2021

SELL
$5.19 - $6.73 $10,281 - $13,332
-1,981 Reduced 6.53%
28,353 $170,000
Q1 2021

May 17, 2021

BUY
$5.74 - $9.67 $9,356 - $15,762
1,630 Added 5.68%
30,334 $192,000
Q4 2020

Feb 16, 2021

BUY
$5.3 - $6.71 $28,222 - $35,730
5,325 Added 22.78%
28,704 $162,000
Q2 2020

Aug 14, 2020

SELL
$4.35 - $8.08 $38,045 - $70,667
-8,746 Reduced 27.22%
23,379 $169,000
Q4 2019

Feb 14, 2020

BUY
$6.38 - $8.73 $34,056 - $46,600
5,338 Added 19.93%
32,125 $258,000
Q2 2019

Aug 14, 2019

BUY
$7.67 - $10.63 $13,161 - $18,241
1,716 Added 6.84%
26,787 $222,000
Q4 2018

Feb 14, 2019

BUY
$7.16 - $16.21 $34,668 - $78,488
4,842 Added 23.94%
25,071 $192,000
Q3 2018

Nov 14, 2018

BUY
$9.7 - $19.65 $31,990 - $64,805
3,298 Added 19.48%
20,229 $352,000
Q2 2018

Aug 14, 2018

BUY
$3.88 - $12.74 $65,692 - $215,700
16,931 New
16,931 $161,000

Others Institutions Holding VKTX

About Viking Therapeutics, Inc.


  • Ticker VKTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 76,688,496
  • Market Cap $3.25B
  • Description
  • Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. The company's lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß), which is in Phase IIb clinical trial...
More about VKTX
Track This Portfolio

Track Voya Investment Management LLC Portfolio

Follow Voya Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Voya Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Voya Investment Management LLC with notifications on news.